324 related articles for article (PubMed ID: 23622415)
1. Axonal dystrophies.
Nardocci N; Zorzi G
Handb Clin Neurol; 2013; 113():1919-24. PubMed ID: 23622415
[TBL] [Abstract][Full Text] [Related]
2. A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy.
Iannello G; Graziano C; Cenacchi G; Cordelli DM; Zuntini R; Papa V; Magistà AM; Gagliardi M; Procopio R; Quattrone A; Annesi G
J Neurol Sci; 2017 Oct; 381():209-212. PubMed ID: 28991683
[TBL] [Abstract][Full Text] [Related]
3. Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy.
Tonelli A; Romaniello R; Grasso R; Cavallini A; Righini A; Bresolin N; Borgatti R; Bassi MT
Clin Genet; 2010 Nov; 78(5):432-40. PubMed ID: 20584031
[TBL] [Abstract][Full Text] [Related]
4. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Thomas M; Hayflick SJ; Jankovic J
Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic delineation of neurodegeneration with brain iron accumulation.
Gregory A; Polster BJ; Hayflick SJ
J Med Genet; 2009 Feb; 46(2):73-80. PubMed ID: 18981035
[TBL] [Abstract][Full Text] [Related]
6. Neuroaxonal dystrophy with dystonia and pallidal involvement.
Simonati A; Trevisan C; Salviati A; Rizzuto N
Neuropediatrics; 1999 Jun; 30(3):151-4. PubMed ID: 10480212
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration with brain iron accumulation.
McNeill A; Chinnery PF
Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
[TBL] [Abstract][Full Text] [Related]
8. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.
Kurian MA; Hayflick SJ
Int Rev Neurobiol; 2013; 110():49-71. PubMed ID: 24209433
[TBL] [Abstract][Full Text] [Related]
9. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
[TBL] [Abstract][Full Text] [Related]
10. Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: An update for the diagnosis.
Iodice A; Spagnoli C; Salerno GG; Frattini D; Bertani G; Bergonzini P; Pisani F; Fusco C
Brain Dev; 2017 Feb; 39(2):93-100. PubMed ID: 27884548
[TBL] [Abstract][Full Text] [Related]
11. Infantile neuroaxonal dystrophy and pantothenate-kinase-associated neurodegeneration: locus heterogeneity.
Hörtnagel K; Nardocci N; Zorzi G; Garavaglia B; Botz E; Meitinger T; Klopstock T
Neurology; 2004 Sep; 63(5):922-4. PubMed ID: 15365152
[TBL] [Abstract][Full Text] [Related]
12. The first Vietnamese patient who presented late onset of pantothenate kinase-associated neurodegeneration diagnosed by whole exome sequencing: A case report.
Tran VK; Vu CD; Tran HA; Lien NTK; Tung NV; Lan NN; Tran HT; Hoang NH
Medicine (Baltimore); 2023 Oct; 102(43):e34853. PubMed ID: 37904482
[TBL] [Abstract][Full Text] [Related]
13. Basal ganglia calcification in a case of PKAN.
Fasano A; Shahidi G; Lang AE; Rohani M
Parkinsonism Relat Disord; 2017 Mar; 36():98-99. PubMed ID: 28024710
[No Abstract] [Full Text] [Related]
14. Beta-propeller protein-associated neurodegeneration (BPAN), a rare form of NBIA: novel mutations and neuropsychiatric phenotype in three adult patients.
Verhoeven WM; Egger JI; Koolen DA; Yntema H; Olgiati S; Breedveld GJ; Bonifati V; van de Warrenburg BP
Parkinsonism Relat Disord; 2014 Mar; 20(3):332-6. PubMed ID: 24368176
[TBL] [Abstract][Full Text] [Related]
15. Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort.
Romani M; Kraoua I; Micalizzi A; Klaa H; Benrhouma H; Drissi C; Turki I; Castellana S; Mazza T; Valente EM; Gouider-Khouja N
Eur J Neurol; 2015 Jan; 22(1):178-86. PubMed ID: 25164370
[TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration with brain iron accumulation: Characterization of clinical, radiological, and genetic features of pediatric patients from Southern India.
Bhardwaj NK; Gowda VK; Saini J; Sardesai AV; Santhoshkumar R; Mahadevan A
Brain Dev; 2021 Nov; 43(10):1013-1022. PubMed ID: 34272103
[TBL] [Abstract][Full Text] [Related]
17. Pattern of disease progression in atypical form of pantothenate-kinase-associated neurodegeneration (PKAN) - Prospective study.
Tomić A; Petrović I; Svetel M; Dobričić V; Dragašević Mišković N; Kostić VS
Parkinsonism Relat Disord; 2015 May; 21(5):521-4. PubMed ID: 25724846
[TBL] [Abstract][Full Text] [Related]
18. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).
Kurian MA; McNeill A; Lin JP; Maher ER
Dev Med Child Neurol; 2011 May; 53(5):394-404. PubMed ID: 21480873
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.
Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL
Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
